These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7100259)

  • 41. Calcium antagonistic effects and the in vitro duration of actions of KW-3049, a new 1,4-dihydropyridine derivative, in isolated canine coronary arteries.
    Karasawa A; Kubo K
    Jpn J Pharmacol; 1988 May; 47(1):35-44. PubMed ID: 3411819
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of anaphylactic histamine release by calcium channel agonists and antagonists.
    Giannella E; Masini E; Palmerani B; Pistelli A; Mannaioni PF
    Agents Actions; 1988 Apr; 23(3-4):185-7. PubMed ID: 2455984
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The calcium-antagonistic fundamental effects of Verapamil on myocardial fibers and smooth muscle cells of the blood vessels].
    Fleckenstein A; Grün G; Byon KY
    Minerva Med; 1975 May; 66(38):1827-37. PubMed ID: 1128823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional interactions of calcium-antagonists in K+-depolarized smooth muscle.
    Spedding M
    Br J Pharmacol; 1983 Nov; 80(3):485-8. PubMed ID: 6640202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibronchoconstrictor activity of the intracellular calcium antagonist HA 1004 in guinea pigs.
    Chapman RW; Tozzi S; Kreutner W
    Pharmacology; 1988; 37(3):187-94. PubMed ID: 2906438
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors.
    Burges RA; Gardiner DG; Gwilt M; Higgins AJ; Blackburn KJ; Campbell SF; Cross PE; Stubbs JK
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):110-9. PubMed ID: 2434785
    [TBL] [Abstract][Full Text] [Related]  

  • 47. History of calcium antagonists.
    Fleckenstein A
    Circ Res; 1983 Feb; 52(2 Pt 2):I3-16. PubMed ID: 6339106
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ca2+ influx insensitive to organic Ca2+ entry blockers contributes to noradrenaline-induced contractions of the isolated guinea pig aorta.
    Gouw MA; Wilffert B; Wermelskirchen D; van Zwieten PA
    Pharmacology; 1990; 40(5):277-87. PubMed ID: 2274573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional antagonism between calcium-antagonists and noradrenaline on isolated guinea-pig atria.
    Görlitz BD; Wagner J; Schümann HJ
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 288(2-3):311-7. PubMed ID: 1161050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Verapamil: a selective antagonist of constrictor substances in dog coronary artery: implications for variant angina.
    Angus JA; Brazenor RM; Le Duc MA
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():15-28. PubMed ID: 6956474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential sensitivity to calcium entry blockade of angiotensin II-induced contractions of rat and guinea-pig aorta.
    van Heiningen PN; van Zwieten PA
    Arch Int Pharmacodyn Ther; 1988; 296():118-30. PubMed ID: 3240015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological profile of a novel 1,5-benzothiazepine calcium antagonist.
    Shiga H; Miyake S; Ideka M; Ito Y; Yanagisawa H; Koike H
    Arzneimittelforschung; 1992 May; 42(5):617-21. PubMed ID: 1530673
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative effects of bepridil and verapamil on isolated coronary and systemic vascular and cardiac muscle.
    Campbell JK; Marshall RJ; Winslow E
    Eur J Pharmacol; 1982 Dec; 86(2):217-28. PubMed ID: 6984392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Inhibitory activity of D-600 on smooth vascular tissue: comparison with nifedipine, verapamil and diltiazem].
    Raddino R; Pelà G; Ferrari A; Ghirarduzzi A; Ferrari R
    Cardiologia; 1987 May; 32(5):469-72. PubMed ID: 3621257
    [No Abstract]   [Full Text] [Related]  

  • 55. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
    Yamaura T; Kase N; Kita H; Uematsu T
    Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of SAS 1310, a new calcium antagonist, on isolated myocardial and smooth muscle preparations.
    Cargnelli G; Padrini R; Piovan D; Moretto R; Bova S
    Eur J Pharmacol; 1987 Apr; 136(2):163-70. PubMed ID: 3595719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bepridil hydrochloride alters potential-dependent and receptor-operated calcium channels in vascular smooth muscle of rabbit aorta.
    Flaim SF; Ratz PH; Swigart SC; Gleason MM
    J Pharmacol Exp Ther; 1985 Jul; 234(1):63-71. PubMed ID: 2409274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological actions of benidipine hydrochloride in several isolated smooth muscles and myocardium.
    Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1722-30. PubMed ID: 3219148
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Calcium channel blockers for the treatment of coronary artery spasm: rationale, effects, and nursing responsibilities.
    Braun LT
    Heart Lung; 1983 May; 12(3):226-32. PubMed ID: 6551368
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Excitation-contraction coupling in cardiac and vascular smooth muscle: modification by calcium-entry blockade.
    McCall D
    Circulation; 1987 Jun; 75(6 Pt 2):V3-14. PubMed ID: 2436829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.